Punica granatumPunica granatum, characterized by a high ellagitannin content, and the cosmetic,nutraceutical and medical use of said cell line or of a derivative thereof.The cell line comprises an amount of ellagitannins (in particular punicalagin, pedunculagin,catechin and gallic acid hexose) greater than 2% w/w, preferably comprised between 4% and50% w/w.The invention also relates to a phytocomplex or an extract obtained from the cell line for usein the treatment of oxidative stress, a cause of chronic inflammatory pathologies or premature skin aging, or as a cosmetic for improving the wellbeing of hair follicles on the scalp.
Perilla frutescensPerilla frutescens, characterized by a high polyphenol and anthocyanin content, and the cosmetic, nutraceutical and medical use of said cell line or a derivative thereof. The meristematic cell line comprises an amount of polyphenols (in particular rosmarinic acidand salvianolic acid B) greater than 1% w/w, preferably comprised between 2.5 % and 10% w/w, more preferably between 3.2 and 5% w/w; and an amount of anthocyanins (in particular shisonin and malonyl-shisonin) greater than 0.05% w/w, preferably comprised between 0.05% and 1% w/w, more preferably between 0.1 and 0.5% w/w. The invention also relates to a phytocomplex or an extract of the cell line and the use thereof in the treatment and/or prevention of inflammations or as an adjuvant in skin repair.
Rhus coriariaRhus coriaria, characterized by a high content of gallic acid and derivatives thereof,and to the cosmetic, nutraceutical and medical use of said cell line or a derivative thereof. The cell line comprises an amount of gallic acid and/or derivatives thereof, preferably hexosegallic acid, pentagalloyl hexoxide, hexagalloyl hexoxide, heptagalloyl hexoxide and octagalloyl hexoxide, that is greater than 3% w/w and preferably comprised between 5% and 20% w/w.The invention also relates to a phytocomplex or extract obtained from the cell line and the use thereof for use in the repair of damaged tissues, to treat irritated skin and to repair excoriations.
The present invention relates to a meristematic cell line selected from tissue, preferably from callus tissue, of a plant belonging to the genus Melissa. The invention also relates to a derivative of the selected cell line, i.e. a phytocomplex or an extract of the cell line. The selected meristematic cell line is characterized by a high rosmarinic acid content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or a derivative thereof.
The present invention relates to a meristematic cell line selected from tissue, preferably callus tissue, of a plant belonging to the genus Rosa. The invention also relates to a derivative of the cell line, i.e. a phytocomplex or an extract of the cell line. The meristematic cell line is characterized by a high polysaccharide content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or of a derivative thereof.
The present invention relates to a meristematic cell line selected from tissue, preferably from callus tissue, of a plant of Daucus carota sativa. The invention also relates to a derivative of the cell line, i.e. a phytocomplex or an extract of the cell line. The selected meristematic cell line is characterized by a high anthocyanin content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or a derivative thereof.
Echinacea purpureaEchinacea purpurea. The invention also relates to a derivative of the cell line, i.e. a phytocomplex or an extract of the cell line. The meristematic cell line is characterized by a high polyphenol content, in particular a high cichoric acid content. Furthermore, the present invention relates to the cosmetic, nutraceutical and medical use of the selected meristematic cell line or a derivative thereof.
patents